title: Effects of autogenous toxoid-bacterin in lactating cows with Staphylococcus aureus subclinical mastitis.
abstract: To evaluate clinical effects of autogenous toxoid-bacterin treatment for Staphylococcus aureus subclinical mastitis in lactating cows, 22 cows which had at least one S. aureus infected quarter were selected from among cows at a S. aureus prevalent dairy farm. Eleven cows were injected with their own autogenous toxoid-bacterin and the others were maintained as non-injected control. In the toxoid-bacterin injected group, 27% of infected quarters were cured during the 12-week trial, compared to 5% in the control group. New intramammary infections with S. aureus were only detected in 3 quarters of the control group. Mean IgG antibody titer against S. aureus somatic antigens and alpha-toxin in serum and milk were significantly increased in the toxoid-bacterin injected group (p<0.05) and remained higher than those of the control group which showed no significant changes (p<0.05). In contrast to the control group, from 3 weeks after the second injection of the toxoid-bacterin injected group, mean S. aureus cfu/ml in milk samples from injected quarters with S. aureus was significantly decreased until the end of the study (p<0.05). In the toxoid-bacterin injected group, significant decreases of mean SCC were detected from milk samples from infected quarters with S. aureus from week 7 to week 10 (p<0.05). These data show that autogenous toxoid-bacterin treatment against S. aureus subclinical mastitis in lactating cows may increase the cure rate of the infections, reduce the severity of the infections and also prevent occurrence of the new infections.
authors.affiliation: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Korea.
authors.forename: C Y
authors.initials: CY
authors.lastname: Hwang
authors.forename: S I
authors.initials: SI
authors.lastname: Pak
authors.forename: H R
authors.initials: HR
authors.lastname: Han
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002417:Cattle; D015169:Colony Count, Microbial / Q000662:veterinary; D003612:Dairying / Q000379:methods; D005260:Female; D007074:Immunoglobulin G / Q000032:analysis; D007774:Lactation; D008414:Mastitis, Bovine / Q000276:immunology / Q000382:microbiology*; D008892:Milk / Q000276:immunology / Q000382:microbiology; D013203:Staphylococcal Infections / Q000662:veterinary*
chemical_list: D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D007074:Immunoglobulin G